Obstructive sleep apnea and the metabolic syndrome

References

• Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc. Am. Thorac. Soc.5, 136–143 (2008).
   PubMedGoogle Scholar
• Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. Proc. Am. Thorac. Soc.5, 242–252 (2008).
   PubMedGoogle Scholar
• Iber C, Ancoli-Israel S, Chesson Jr AL, Quan SF. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. American Academy of Sleep Medicine, IL, USA (2007).
   Google Scholar
• Young T, Palta M, Dempsey J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med.328, 230–235 (1993).
   Google Scholar
• Bearpark H, Elliott L, Grunstein R et al. Snoring and sleep apnea: a population study in Australian men. Am. J. Respir. Crit. Care Med.163, 608–613 (1995).
   Google Scholar
• Ip MSM, Lam B, Tang LC, Lauder IJ et al. A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences. Chest125, 127–134 (2004).
   PubMedGoogle Scholar
• Kim JK, In KH, Kim JH et al. Prevalence of sleep-disordered breathing in middle-aged Korean Men and Women. Am. J. Respir. Crit. Care Med.170, 1108–1113 (2004).
   PubMed Web of Science ®Google Scholar
• Udwadia ZF, Doshi AV, Lonhar SG, Singh CL. Prevalence of sleep disordered breathing and sleep apnea in middle-aged urban Indian men. Am. J. Respir. Crit. Care Med.169, 168–173 (2004).
   PubMed Web of Science ®Google Scholar
• Sharma SK, Kumpawat S, Banga A, Goel A. Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India. Chest130, 149–156 (2006).
   PubMed Web of Science ®Google Scholar
• Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 years. Am. J. Respir. Crit. Care Med.163, 685–689 (2001).
   PubMed Web of Science ®Google Scholar
• Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: prevalence and severity. Am. J. Respir. Crit. Care Med.157, 144–148 (1998).
   PubMed Web of Science ®Google Scholar
• Kohler MJ, van den Heuvel CJ. Is there a clear link between overweight/obesity and sleep disordered breathing in children? Sleep Med. Rev.12, 347–361 (2008).
   PubMedGoogle Scholar
• McNicholas WT, Bonsignore MR and the Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J.29, 156–178 (2007).
   PubMed Web of Science ®Google Scholar
• Marin JM, Carrizo SJ, Vicente L, Agusti AGN. Long term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet365, 1046–1053 (2005).
   PubMed Web of Science ®Google Scholar
• Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea – a 7-year follow up. Am. J. Respir. Crit. Care Med.166, 159–165 (2002).
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet365, 1415–1428 (2005).
   PubMed Web of Science ®Google Scholar
• American Medical Association. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA285, 2486–2497 (2001).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet366, 1059–1062 (2005).
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation. Appropriate BMI for Asian populations and its implications for policy and intervention strategies. Lancet363(9403), 157–163 (2004).
   PubMed Web of Science ®Google Scholar
• WHO. Obesity: preventing and managing the global epidemic. WHO Technical report series 894. Presented at: WHO Consultation on Obesity. Geneva, Switzerland, 3–5 June 1997.
   Google Scholar
• Borona E, Kiechl S, Willeit J et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross sectional data from the Bruneck Study. Int. J. Obese.27, 1283–1289 (2003).
   Google Scholar
• Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome prevalence in worldwide populations. Endocrinol. Metab. Clin. North Am.33, 351–375 (2004).
   PubMed Web of Science ®Google Scholar
• Gale EA, Alberti KGMM. Should we dump the metabolic syndrome? BMJ336, 640–642 (2008).
   PubMedGoogle Scholar
• Satter N, McConnachie A, Sharper G et al. Can metabolic syndromes usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet371(9628), 1927–1935 (2008).
   PubMedGoogle Scholar
• Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. ‘Syndrome Z’: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax53, S25–S28 (1998).
   PubMedGoogle Scholar
• Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med. Rev.9, 211–224 (2005).
   PubMed Web of Science ®Google Scholar
• Coughlin SR, Mawdsley L, Mugarza JA et al. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur. Heart J.25, 735–741 (2004).
   PubMed Web of Science ®Google Scholar
• Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc. Diabetol.5, 22 (2006).
   PubMedGoogle Scholar
• Lam JCM, Lam B, Lam CL et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese subjects in Hong Kong. Resp. Med.100(6), 980–987 (2006).
   PubMedGoogle Scholar
• Sasanabe R, Banno K, Otake K et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens. Res.29, 315–322 (2006).
   PubMed Web of Science ®Google Scholar
• Cho N, Joo S, Kim J et al. Relation of habitual snoring with components of metabolic syndrome in Korean adults. Diabetes Res. Clin. Pract.71, 256–263 (2006).
   PubMedGoogle Scholar
• Parish JM, Adam T, Facchiano L et al. Relationship of metabolic syndrome and obstructive sleep apnea. J. Sleep Med.3, 467–472 (2007).
   Google Scholar
• Salord N, Mayos M, Miralda R, Perez A. Respiratory sleep disturbances in patients undergoing gastric bypass surgery and their relation to metabolic syndrome. Obes. Surg19(1), 74–79 (2008).
   PubMedGoogle Scholar
• Kono M, Tatsumi K, Saibara T et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest131, 1387–1392 (2007).
   PubMed Web of Science ®Google Scholar
• Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med.8, 12–17 (2007).
   PubMedGoogle Scholar
• Couglin SR, Mawdsley L, Mugarza JA, Wilding JPH, Calverley PMA. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur. Respir. J.29, 720–727 (2007).
   PubMedGoogle Scholar
• Ambrosetti M, Lucioni AM, Conti S, Pedretti RF, Neri M. Metabolic syndrome in obstructive sleep apnea and related cardiovascular risk. J. Cardiovasc. Med. (Hagerstown)7, 826–829 (2006).
   PubMed Web of Science ®Google Scholar
• Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest134, 686–692 (2008).
   PubMed Web of Science ®Google Scholar
• Schwartz AR, Patil SP, Laffan AM, Polotsky VY, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanism and therapeutic approaches. Proc. Am. Thorac. Soc.5(2), 185–192 (2008).
   PubMedGoogle Scholar
• de Sousa AGP, Cercato C, Mancini MC, Halpern A. Obesity and obstructive sleep apnea. Obes. Rev.9, 340–354 (2008).
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Papanicolaou DA, Bixler EO et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J. Clin. Endocrinol. Metab.85(3), 1151–1158 (2000).
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Dempsey J, Skareyd J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA284, 3015–3021 (2000).
   PubMed Web of Science ®Google Scholar
• Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med.1(3), e62 (2004).
   PubMed Web of Science ®Google Scholar
• Chin K, Shimizu K, Nakamura T et al. Changes in intra-abdominal fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation100, 706–712 (1999).
   PubMed Web of Science ®Google Scholar
• Lam JCM, Lam B, Yao TJ et al. A double-blind randomized controlled trial of nasal continuous positive airway pressure treatment on insulin sensitivity in men with obstructive sleep apnea. Respirology13(Suppl. 5), A135 (2008).
   Google Scholar
• Lam B, Sam K, Mok WY et al. Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax62(4), 354–359 (2007).
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. Obes. Res.6(Suppl. 2), 51S–209S (1998).
   PubMedGoogle Scholar
• Fritscher LG, Mottin CC, Canani S, Chatkin JM. Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obes. Surg.17(1), 95–99 (2007).
   PubMedGoogle Scholar
• Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch. Intern. Med.157(15), 1746–1752 (1997).
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med.342(19), 1378–1384 (2000).
   PubMed Web of Science ®Google Scholar
• Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, and hypertension in a large community-based study. JAMA283, 1829–1836 (2000).
   PubMed Web of Science ®Google Scholar
• Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ320, 479–482 (2000).
   PubMed Web of Science ®Google Scholar
• Bixler EO, Vgontzas AN, Lin HM et al. Association of hypertension and sleep-disordered breathing. Arch. Intern. Med.160, 2289–2295 (2000).
   PubMed Web of Science ®Google Scholar
• Davies C, Crosby J, Mullins R et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnea and normal matched control subjects. Thorax55, 736–740 (2000).
   PubMed Web of Science ®Google Scholar
• Li AM, Au CT, Sung RY et al. Ambulatory blood pressure in children with obstructive sleep apnoea: a community based study. Thorax63(9), 803–809 (2008).
   PubMedGoogle Scholar
• Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in sleep apnea hypopnea syndrome. Am. J. Respir. Crit. Care Med.163, 344–348 (2001).
   PubMed Web of Science ®Google Scholar
• Pepperell JC, Ramitassingh-Dow S, Crostheaite N et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized parallel trial. Lancet359, 204–210 (2002).
   PubMed Web of Science ®Google Scholar
• Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation107, 68–73 (2003).
   PubMed Web of Science ®Google Scholar
• Campos-Rodriguez, Grilo-Reina A, Perez-Ronchel J et al. Effect of continuous positive airway pressue on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest129, 1459–1467 (2006).
   PubMed Web of Science ®Google Scholar
• Hui DS, To KW, Ko FW et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax61(12), 1083–1090 (2006).
   PubMedGoogle Scholar
• Haentijens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome – evidence from a meta-analysis of placebo-controlled randomized trials. Arch. Intern. Med.167, 757–765 (2007).
   PubMedGoogle Scholar
• Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive pressure on blood pressure in obstructive sleep apnea. Hypertension50, 417–423 (2007).
   PubMed Web of Science ®Google Scholar
• Alajmi M, Mulgrew AT, Fox J et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung185, 67–72 (2007).
   PubMed Web of Science ®Google Scholar
• Barnes M, Houston D, Worsnop CJ et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am. J. Respir. Crit. Care Med.165(6), 773–780 (2002).
   PubMed Web of Science ®Google Scholar
• Barbé F, Mayoralas LR, Duran J et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann. Intern. Med.134(11), 1015–1023 (2001).
   PubMed Web of Science ®Google Scholar
• Robinson GV, Smith DM, Langford BA et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur. Resp. J.27, 1229–1235 (2006).
   PubMed Web of Science ®Google Scholar
• Ip MS. Obstructive sleep apnoea, insulin resistance and sleepiness. Thorax63(11), 939–940 (2008).
   PubMedGoogle Scholar
• Börntorp P. Metabolic implications of body fat distribution. Diabetes Care14, 1132–1143 (1991).
   PubMedGoogle Scholar
• Tasali and Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc. Am. Thorac. Soc.5(2), 207–217 (2008).
   PubMedGoogle Scholar
• Ip MSM, Lam B, Ng MMT, Lam WK, Tsang KWT, Lam KSL. Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med.165, 670–676 (2002).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep disordered breathing, glucose intolerance, insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol.160, 521–530 (2004).
   PubMed Web of Science ®Google Scholar
• Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and Type II diabetes: a population-based study. Am. J. Respir. Crit. Care Med.172, 1590–1595 (2005).
   PubMed Web of Science ®Google Scholar
• Harsch IA, Schahin SP, Radespiel-Tröger FN et al. Continuous positive airway pressure treatment rapidly improves insulin resistance in patients with obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med.169, 156–162 (2004).
   PubMed Web of Science ®Google Scholar
• Schahin SP, Nechanitzky T, Dittel C et al. Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome. Med. Sci. Monit.14(3), CR117–CR121 (2008).
   PubMedGoogle Scholar
• Barcelo A, Barbe F, de la Pena M et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax63, 946–950 (2008).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am. J. Respir. Crit. Care Med.179(3), 235–240 (2009).
   PubMed Web of Science ®Google Scholar
• West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and Type 2 diabetes. Thorax62(11), 969–974 (2007).
   PubMed Web of Science ®Google Scholar
• Anderson AJ, Sobocinski KA, Freedman DS et al. Body fat distribution, plasma lipids and lipoproteins. Arteriosclerosis8, 88–94 (1998).
   Google Scholar
• Newman AB, Nieto FJ. Relationship of sleep-disordered breathing to cardiovascular risk factors. The Sleep Heart Health Study. Am. J. Epidemiol.154, 50–59 (2001).
   PubMed Web of Science ®Google Scholar
• Ip MSM, Lam KSL, Ho CM, Tsang KWT, Lam WK. Serum leptin and vascular risk factors in OSA. Chest118(3), 580–586 (2000)
   PubMed Web of Science ®Google Scholar
• Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest122, 829–839 (2002).
   PubMed Web of Science ®Google Scholar
• McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea. Am. J. Respir. Crit. Care Med.175, 190–195 (2007).
   PubMed Web of Science ®Google Scholar
• Borgel J, Sanner BM, Bittlinsky A et al. Obstructive sleep apnoea and its therapy influence high density lipoprotein cholesterol serum levels. Eur. Respir. J.27, 121–127 (2006).
   PubMed Web of Science ®Google Scholar
• Robinson GV, Pepperrell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep data from randomized controlled trials. Thorax59(9), 777–782 (2004).
   PubMed Web of Science ®Google Scholar
• Steinberg D. Low density lipoprotein oxidation and its pathological significance. J. Biol. Chem.272, 20963–20966 (1997).
   PubMed Web of Science ®Google Scholar
• Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AGN. Abnormal lipid peroxidation in patients with sleep apnea. Eur. Respir. J.16, 644–647 (2000).
   PubMedGoogle Scholar
• Lavie L. Oxidative stress – a unifying paradigm in obstructive sleep apnea and comorbidities. Prog. Cardiovasc. Dis.51(4), 303–312 (2009).
   PubMed Web of Science ®Google Scholar
• Tan KCB, Chow WS, Lam JC et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis184(2), 377–382 (2006).
   PubMed Web of Science ®Google Scholar
• Jun J, Polotsky VY. Sleep disordered breathing and metabolic effects: evidence from animal models. Sleep Med. Clin.2, 263–277 (2007).
   PubMedGoogle Scholar
• Somers VK, Dyken ME, Clary MP et al. Sympathetic neural mechanisms in OSA. J. Clin. Invest.96, 1897–1904 (1995).
   PubMed Web of Science ®Google Scholar
• Grassi G, Facchini A, Trevano FQ et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension46, 321–325 (2005).
   PubMed Web of Science ®Google Scholar
• Wolk R, Shamsuzzaman, Somers VK. Obesity, sleep apnea and hypertension. Hypertension42, 1067–1074 (2003).
   PubMed Web of Science ®Google Scholar
• Dopp JM, Pharma D, Reichmuth KJ, Morgan B. Obstructive sleep panea and hypertension: mechanisms, evaluation and managment. Central Hypertension Reports9, 529–534 (2007).
   PubMed Web of Science ®Google Scholar
• Moller DS, Lind P, Strunge B et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am. J. Hypertens.16, 274–280 (2003).
   PubMed Web of Science ®Google Scholar
• Pratt-Ubunama MN, Nichizaka MK, Boedefeld RL et al. Plasma aldosterone is related to severity of obstructive sleep apnea subjects with resistant hypertension. Chest131, 453–459 (2007).
   PubMed Web of Science ®Google Scholar
• Chan SLF, Pernett CW, Morgan NG. Differential expression of α2-adrenoceptor subtypes in purified rat pancreatic islet A- and B-cells. Cell Signal.9, 71–78 (1997).
   PubMed Web of Science ®Google Scholar
• Lam JC, Xu A, Tam S et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep31(12), 1721–1727 (2008).
   PubMed Web of Science ®Google Scholar
• Iiyori N, Alonso LC, Li J et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am. J. Respir. Crit. Care Med.175, 851–857 (2007).
   PubMed Web of Science ®Google Scholar
• Cooper VL, Pearson SB, Bowker CM, Elliott MW, Hainsworth R. Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia – a mechanism for promoting hypertension in obstructive sleep apnoea. J. Physiol.568(Pt 2), 677–687 (2005).
   PubMed Web of Science ®Google Scholar
• Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of Type 2 diabetes. Diabetes Care29, 657–661 (2006).
   PubMed Web of Science ®Google Scholar
• Ip MSM, Mokhlesi B. Sleep and glucose intolerance/diabetes mellitus. Sleep Med. Clin.2, 19–29 (2007).
   PubMedGoogle Scholar
• Van Cauter E, Holmback U, Knutson K et al. Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm. Res.67, 2–9 (2007).
   PubMedGoogle Scholar
• Dadoun F, Darmon P, Achard V et al. Effect of sleep apnoea syndrome on the circadian profile of cortisol in obese men. Am. J. Physiol. Endocrinol. Metab.293, E466–E474 (2007).
   Google Scholar
• Trakada G, Chrousos G, Pejovic S, Vgontzas A. Sleep apnea and its association with the stress system, inflammation, insulin resistance and visceral obesity. Sleep Med. Clin.2, 251–261 (2007).
   PubMedGoogle Scholar
• Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic. Biol. Med.40, 1683–1692 (2006).
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br. J. Nutr.100, 227–235 (2008).
   PubMed Web of Science ®Google Scholar
• Polotsky VY, Li J, Punjabi NM et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol.552, 253–264 (2003).
   PubMed Web of Science ®Google Scholar
• Li J, Savransky V, Nanayakkara A, Smith PL, O’Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J. Appl. Physiol.102, 557–563 (2007).
   PubMed Web of Science ®Google Scholar
• Jun J, Savransky V, Nanayakkara A et al. Intermittent hypoxia has organ-specific effects of oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol.295(4), R1274–R1281 (2008).
   Google Scholar
• Ip MSM, Lam B, Chan LY et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care Med.162, 2166–2171 (2000).
   PubMed Web of Science ®Google Scholar
• Schulz R, Mahmoudi S, Hattar K et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am. J. Respir. Crit. Care Med.162, 566–570 (2000).
   PubMed Web of Science ®Google Scholar
• Jordan W, Cohrs S, Degner D et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J. Neural Transm.113, 239–254 (2006).
   PubMed Web of Science ®Google Scholar
• Sutherland J, McKinnley B, Eckel RH. The metabolic syndrome and inflammation. Metabolic Syndr. Rel. Disord.2, 82–104 (2004).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature444, 860–867 (2006).
   PubMed Web of Science ®Google Scholar
• Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res.96, 939–949 (2005).
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett.580, 2917–2921 (2006).
   PubMed Web of Science ®Google Scholar
• Lefebvre B, Pépin JL, Baguet JP et al. Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea? Eur. Respir. J.32(1), 113–120 (2008).
   PubMedGoogle Scholar
• Hui DS, Ko FW, Fok JP et al. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest125, 1768–1775 (2004).
   PubMed Web of Science ®Google Scholar
• Chin K, Nakamura T, Shimizu K et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am. J. Med.109, 562–567 (2000).
   PubMed Web of Science ®Google Scholar
• Yokoe T, Minoguchi K, Matsuo H et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation107, 1129–1134 (2003).
   PubMed Web of Science ®Google Scholar
• Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med.174, 824–830 (2006).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep30, 29–34 (2007).
   PubMed Web of Science ®Google Scholar
• von Kanel R, Loredo JS, Ancoli-Israel S, Mills PJ, Dimsdale JE. Elevated plasminogen activator inhibitor 1 in sleep apnea and its relation to the metabolic syndrome: an investigation in 2 different study samples. Metabolism56, 969–976 (2007).
   PubMedGoogle Scholar
• Peled N, Kassirer M, Shitrit D et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Res. Med.101, 1696–1701 (2007).
   PubMedGoogle Scholar
• Gozal D, Serpero LD, Capdevila OS, Kheirandish-Gozal L. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med.9, 254–259 (2008).
   PubMed Web of Science ®Google Scholar
• Lam DCL, Xu A, Lam KSL et al. Serum adipocyte-fatty acid binding protein (A-FABP) level is elevated in severe obstructive sleep apnea (OSA) and correlates with insulin resistance. Eur. Respir. J.33, 346–351 (2009).
   PubMedGoogle Scholar
• Polotsky VY, Smaldone MC, Scharf MT et al. Impact of interrupted leptin pathways on ventilatory control. J. Appl. Physiol.96(3), 991–998 (2004).
   PubMed Web of Science ®Google Scholar
• Patel SR, Palmer LJ, Larkin EK, Jenny NS, White DP, Redline S. Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep27, 235–239 (2004).
   PubMed Web of Science ®Google Scholar
• Sanner BM, Kollhosser P, Buechner N, Zidek W, Tepel M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur. Respir. J.23, 601–604 (2004).
   PubMedGoogle Scholar
• Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea-oxidative stress, inflammation, and much more. Am. J. Respir. Crit. Care Med.177, 369–375 (2008).
   PubMed Web of Science ®Google Scholar
• Riha RL, Diefenbach K, Jennum P, McNicholas WT; Management Committee COST B26 Action on Sleep Apnoea Syndrome. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome. Sleep Med. Rev.12(1), 49–63 (2008).
   PubMedGoogle Scholar